Astrocytes and the regulation of cerebral blood flow.

PubWeight™: 2.27‹?› | Rank: Top 2%

🔗 View Article (PMID 19162338)

Published in Trends Neurosci on January 21, 2009

Authors

Raymond C Koehler1, Richard J Roman, David R Harder

Author Affiliations

1: Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University, Baltimore, MD 21287, USA. rkoehler@jhmi.edu

Articles citing this

(truncated to the top 100)

Astrocytes: biology and pathology. Acta Neuropathol (2009) 8.43

Engaging neuroscience to advance translational research in brain barrier biology. Nat Rev Neurosci (2011) 2.40

Astrocytic endfoot Ca2+ and BK channels determine both arteriolar dilation and constriction. Proc Natl Acad Sci U S A (2010) 1.90

Synapse location during growth depends on glia location. Cell (2013) 1.80

Interpreting oxygenation-based neuroimaging signals: the importance and the challenge of understanding brain oxygen metabolism. Front Neuroenergetics (2010) 1.77

In vivo 3D morphology of astrocyte-vasculature interactions in the somatosensory cortex: implications for neurovascular coupling. J Cereb Blood Flow Metab (2010) 1.66

The neurovascular unit in the setting of stroke. J Intern Med (2010) 1.66

Reactive astrocytes as therapeutic targets for CNS disorders. Neurotherapeutics (2010) 1.60

Age-associated reductions in cerebral blood flow are independent from regional atrophy. Neuroimage (2010) 1.55

Neurological diseases as primary gliopathies: a reassessment of neurocentrism. ASN Neuro (2012) 1.50

In vivo stimulus-induced vasodilation occurs without IP3 receptor activation and may precede astrocytic calcium increase. J Neurosci (2013) 1.47

Functions of astrocytes and their potential as therapeutic targets. Neurotherapeutics (2010) 1.44

Adenosine signaling and function in glial cells. Cell Death Differ (2009) 1.39

Decreased upright cerebral blood flow and cerebral autoregulation in normocapnic postural tachycardia syndrome. Am J Physiol Heart Circ Physiol (2009) 1.38

Frontiers in optical imaging of cerebral blood flow and metabolism. J Cereb Blood Flow Metab (2012) 1.36

Toll-like receptor 4 is required for α-synuclein dependent activation of microglia and astroglia. Glia (2012) 1.32

Dynamic models of BOLD contrast. Neuroimage (2012) 1.32

Molecular profiles of drinking alcohol to intoxication in C57BL/6J mice. Alcohol Clin Exp Res (2011) 1.27

Astrocyte pathology in major depressive disorder: insights from human postmortem brain tissue. Curr Drug Targets (2013) 1.26

Rapid stimulus-evoked astrocyte Ca2+ elevations and hemodynamic responses in mouse somatosensory cortex in vivo. Proc Natl Acad Sci U S A (2013) 1.24

Neurovascular function in Alzheimer's disease patients and experimental models. J Cereb Blood Flow Metab (2011) 1.18

Astrocytes protect oligodendrocyte precursor cells via MEK/ERK and PI3K/Akt signaling. J Neurosci Res (2010) 1.08

VennPlex--a novel Venn diagram program for comparing and visualizing datasets with differentially regulated datapoints. PLoS One (2013) 1.08

The effects of psychostimulant drugs on blood brain barrier function and neuroinflammation. Front Pharmacol (2012) 1.07

A review of calibrated blood oxygenation level-dependent (BOLD) methods for the measurement of task-induced changes in brain oxygen metabolism. NMR Biomed (2012) 1.07

Glial dysfunction in the pathogenesis of α-synucleinopathies: emerging concepts. Acta Neuropathol (2011) 1.06

Inhibition of inducible nitric oxide synthase reverses the loss of functional hyperemia in diabetic retinopathy. Glia (2010) 1.05

Cerebral blood flow modulation by Basal forebrain or whisker stimulation can occur independently of large cytosolic Ca2+ signaling in astrocytes. PLoS One (2013) 1.04

Catechin treatment improves cerebrovascular flow-mediated dilation and learning abilities in atherosclerotic mice. Am J Physiol Heart Circ Physiol (2010) 1.03

Prospects for quantitative fMRI: investigating the effects of caffeine on baseline oxygen metabolism and the response to a visual stimulus in humans. Neuroimage (2011) 1.02

Insulin promotes glycogen storage and cell proliferation in primary human astrocytes. PLoS One (2011) 1.02

Astrogliosis in amyotrophic lateral sclerosis: role and therapeutic potential of astrocytes. Neurotherapeutics (2010) 1.02

Role of epoxyeicosatrienoic acids as autocrine metabolites in glutamate-mediated K+ signaling in perivascular astrocytes. Am J Physiol Cell Physiol (2010) 1.01

Cellular therapy to target neuroinflammation in amyotrophic lateral sclerosis. Cell Mol Life Sci (2013) 1.00

Caffeine and the control of cerebral hemodynamics. J Alzheimers Dis (2010) 1.00

The physics of functional magnetic resonance imaging (fMRI). Rep Prog Phys (2013) 0.99

Astrocytes, therapeutic targets for neuroprotection and neurorestoration in ischemic stroke. Prog Neurobiol (2015) 0.99

Transcriptional profiling of human brain endothelial cells reveals key properties crucial for predictive in vitro blood-brain barrier models. PLoS One (2012) 0.98

Postural neurocognitive and neuronal activated cerebral blood flow deficits in young chronic fatigue syndrome patients with postural tachycardia syndrome. Am J Physiol Heart Circ Physiol (2011) 0.97

Protection after stroke: cellular effectors of neurovascular unit integrity. Front Cell Neurosci (2014) 0.97

Astrocyte regulation of cerebral vascular tone. Am J Physiol Heart Circ Physiol (2013) 0.95

The BOLD post-stimulus undershoot, one of the most debated issues in fMRI. Neuroimage (2012) 0.95

Beyond neurovascular coupling, role of astrocytes in the regulation of vascular tone. Neuroscience (2015) 0.95

Purinergic mechanisms in gliovascular coupling. Semin Cell Dev Biol (2011) 0.94

Cytochrome P450 eicosanoids and cerebral vascular function. Expert Rev Mol Med (2011) 0.94

Multiple oxygen tension environments reveal diverse patterns of transcriptional regulation in primary astrocytes. PLoS One (2011) 0.90

Coverage of blood vessels by astrocytic endfeet is reduced in major depressive disorder. Biol Psychiatry (2012) 0.90

Pioglitazone improves reversal learning and exerts mixed cerebrovascular effects in a mouse model of Alzheimer's disease with combined amyloid-β and cerebrovascular pathology. PLoS One (2013) 0.90

Fibro-vascular coupling in the control of cochlear blood flow. PLoS One (2011) 0.90

Intermediate-conductance calcium-activated potassium channels participate in neurovascular coupling. Br J Pharmacol (2011) 0.89

Functional MRI in mice lacking IP3-dependent calcium signaling in astrocytes. J Cereb Blood Flow Metab (2014) 0.89

Middle cerebral O₂ delivery during the modified Oxford maneuver increases with sodium nitroprusside and decreases during phenylephrine. Am J Physiol Heart Circ Physiol (2013) 0.89

The plausibility of a role for mercury in the etiology of autism: a cellular perspective. Toxicol Environ Chem (2011) 0.88

Cerebral blood flow response to neural activation after acute ischemic stroke: a failure of myogenic regulation? J Neurol (2013) 0.87

Epoxyeicosatrienoic acid-dependent cerebral vasodilation evoked by metabotropic glutamate receptor activation in vivo. Am J Physiol Heart Circ Physiol (2011) 0.87

Vascular inward rectifier K+ channels as external K+ sensors in the control of cerebral blood flow. Microcirculation (2015) 0.86

The new FDG brain revolution: the neurovascular unit and the default network. Eur J Nucl Med Mol Imaging (2010) 0.86

Vascular tone and neurovascular coupling: considerations toward an improved in vitro model. Front Neuroenergetics (2010) 0.86

ATP hydrolysis pathways and their contributions to pial arteriolar dilation in rats. Am J Physiol Heart Circ Physiol (2011) 0.86

Astroglial glutamate transporters coordinate excitatory signaling and brain energetics. Neurochem Int (2016) 0.86

Cerebral blood flow is an earlier indicator of perfusion abnormalities than cerebral blood volume in Alzheimer's disease. J Cereb Blood Flow Metab (2014) 0.86

Interactions between adenosine and K+ channel-related pathways in the coupling of somatosensory activation and pial arteriolar dilation. Am J Physiol Heart Circ Physiol (2010) 0.86

Enhanced parenchymal arteriole tone and astrocyte signaling protect neurovascular coupling mediated parenchymal arteriole vasodilation in the spontaneously hypertensive rat. J Cereb Blood Flow Metab (2015) 0.86

Subarachnoid hemorrhage, spreading depolarizations and impaired neurovascular coupling. Stroke Res Treat (2013) 0.86

Retinal Macroglial Responses in Health and Disease. Biomed Res Int (2016) 0.85

Targeting the neurovascular unit for treatment of neurological disorders. Pharmacol Ther (2010) 0.85

Neurophysiological, metabolic and cellular compartments that drive neurovascular coupling and neuroimaging signals. Front Neuroenergetics (2013) 0.85

Cellular Links between Neuronal Activity and Energy Homeostasis. Front Pharmacol (2012) 0.85

A systematic review of cerebral hemodynamic responses to neural activation following stroke. J Neurol (2013) 0.85

Relative contribution of cyclooxygenases, epoxyeicosatrienoic acids, and pH to the cerebral blood flow response to vibrissal stimulation. Am J Physiol Heart Circ Physiol (2011) 0.85

Pyramidal cells and cytochrome P450 epoxygenase products in the neurovascular coupling response to basal forebrain cholinergic input. J Cereb Blood Flow Metab (2012) 0.85

Impaired neurovascular coupling to ictal epileptic activity and spreading depolarization in a patient with subarachnoid hemorrhage: possible link to blood-brain barrier dysfunction. Epilepsia (2012) 0.85

Electrophysiological correlates of the BOLD signal for EEG-informed fMRI. Hum Brain Mapp (2014) 0.84

Astrocyte inositol triphosphate receptor type 2 and cytosolic phospholipase A2 alpha regulate arteriole responses in mouse neocortical brain slices. PLoS One (2012) 0.84

Functional role of astrocyte glutamate receptors and carbon monoxide in cerebral vasodilation response to glutamate. Am J Physiol Heart Circ Physiol (2012) 0.84

Activation of astroglial calcium signaling by endogenous metabolites succinate and gamma-hydroxybutyrate in the nucleus accumbens. Front Neuroenergetics (2011) 0.84

Placental ischemia in pregnant rats impairs cerebral blood flow autoregulation and increases blood-brain barrier permeability. Physiol Rep (2014) 0.83

Genetic variation in soluble epoxide hydrolase: association with outcome after aneurysmal subarachnoid hemorrhage. J Neurosurg (2014) 0.83

Study of the spatial correlation between neuronal activity and BOLD fMRI responses evoked by sensory and channelrhodopsin-2 stimulation in the rat somatosensory cortex. J Mol Neurosci (2014) 0.83

Nanomicellar formulation of coenzyme Q10 (Ubisol-Q10) effectively blocks ongoing neurodegeneration in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model: potential use as an adjuvant treatment in Parkinson's disease. Neurobiol Aging (2014) 0.82

ASTROCYTES: EMERGING STARS IN LEUKODYSTROPHY PATHOGENESIS. Transl Neurosci (2013) 0.82

Phosphodiesterase-5 Inhibitors: Action on the Signaling Pathways of Neuroinflammation, Neurodegeneration, and Cognition. Mediators Inflamm (2015) 0.82

Cardiorenal metabolic syndrome and diabetic cognopathy. Cardiorenal Med (2013) 0.82

Hepatic stellate cells and astrocytes: Stars of scar formation and tissue repair. Cell Cycle (2011) 0.82

Cytochrome P450 2J2 is protective against global cerebral ischemia in transgenic mice. Prostaglandins Other Lipid Mediat (2012) 0.82

Postsynaptic and spiking activity of pyramidal cells, the principal neurons in the rat hippocampal CA1 region, does not control the resultant BOLD response: a combined electrophysiologic and fMRI approach. J Cereb Blood Flow Metab (2015) 0.81

Noninvasive functional imaging of cerebral blood volume with vascular-space-occupancy (VASO) MRI. NMR Biomed (2013) 0.81

Chronic stress modulates regional cerebral glucose transporter expression in an age-specific and sexually-dimorphic manner. Physiol Behav (2013) 0.81

Whole brain radiation-induced vascular cognitive impairment: mechanisms and implications. J Vasc Res (2013) 0.81

The roadmap for estimation of cell-type-specific neuronal activity from non-invasive measurements. Philos Trans R Soc Lond B Biol Sci (2016) 0.80

EEG and functional ultrasound imaging in mobile rats. Nat Methods (2015) 0.80

Transplantation of stem cell-derived astrocytes for the treatment of amyotrophic lateral sclerosis and spinal cord injury. World J Stem Cells (2015) 0.80

Coupling of cerebral blood flow and oxygen metabolism is conserved for chromatic and luminance stimuli in human visual cortex. Neuroimage (2012) 0.80

Cerebral blood flow and autoregulation: current measurement techniques and prospects for noninvasive optical methods. Neurophotonics (2016) 0.79

Unveiling astrocytic control of cerebral blood flow with optogenetics. Sci Rep (2015) 0.79

Mechanical restriction of intracortical vessel dilation by brain tissue sculpts the hemodynamic response. Neuroimage (2015) 0.79

Deregulation of hepatic insulin sensitivity induced by central lipid infusion in rats is mediated by nitric oxide. PLoS One (2009) 0.79

Enteral supplements of a carbon monoxide donor CORM-A1 protect against cerebrovascular dysfunction caused by neonatal seizures. J Cereb Blood Flow Metab (2014) 0.78

Carbon dioxide influence on nitric oxide production in endothelial cells and astrocytes: cellular mechanisms. Brain Res (2011) 0.78

Feedback to distal dendrites links fMRI signals to neural receptive fields in a spiking network model of the visual cortex. J Neurophysiol (2015) 0.78

Articles by these authors

Efficient transgenic rat production by a lentiviral vector. Am J Physiol Heart Circ Physiol (2007) 3.07

Antihypertensive effect of glucagon-like peptide 1 in Dahl salt-sensitive rats. J Hypertens (2003) 2.35

Degenerin/epithelial Na+ channel proteins: components of a vascular mechanosensor. Hypertension (2004) 2.15

Identification of putative gene based markers of renal toxicity. Environ Health Perspect (2004) 1.85

Role of astrocytes in cerebrovascular regulation. J Appl Physiol (1985) (2006) 1.82

The intermediate-conductance calcium-activated potassium channel KCa3.1 contributes to atherogenesis in mice and humans. J Clin Invest (2008) 1.82

Role of 20-hydroxyeicosatetraenoic acid (20-HETE) in vascular system. J Smooth Muscle Res (2005) 1.79

Inhibition of the formation of EETs and 20-HETE with 1-aminobenzotriazole attenuates pressure natriuresis. Am J Physiol Regul Integr Comp Physiol (2004) 1.76

Multiple blood pressure loci on rat chromosome 13 attenuate development of hypertension in the Dahl S hypertensive rat. Physiol Genomics (2007) 1.57

Astrocytes directly influence tumor cell invasion and metastasis in vivo. PLoS One (2013) 1.56

20-hydroxyeicosatetraeonic acid: a new target for the treatment of hypertension. J Cardiovasc Pharmacol (2010) 1.55

Elevated production of 20-HETE in the cerebral vasculature contributes to severity of ischemic stroke and oxidative stress in spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol (2008) 1.54

Activation of vascular endothelial growth factor through reactive oxygen species mediates 20-hydroxyeicosatetraenoic acid-induced endothelial cell proliferation. J Pharmacol Exp Ther (2007) 1.53

Interaction of mechanisms involving epoxyeicosatrienoic acids, adenosine receptors, and metabotropic glutamate receptors in neurovascular coupling in rat whisker barrel cortex. J Cereb Blood Flow Metab (2007) 1.48

Functional polymorphism in human CYP4F2 decreases 20-HETE production. Physiol Genomics (2007) 1.47

Application of chromosomal substitution techniques in gene-function discovery. J Physiol (2004) 1.47

Suppression of cortical functional hyperemia to vibrissal stimulation in the rat by epoxygenase inhibitors. Am J Physiol Heart Circ Physiol (2002) 1.45

Role of 20-hydroxyeicosatetraenoic acid in the renal and vasoconstrictor actions of angiotensin II. Am J Physiol Regul Integr Comp Physiol (2002) 1.43

Inhibitors of cytochrome P450 4A suppress angiogenic responses. Am J Pathol (2005) 1.41

Chromosome substitution reveals the genetic basis of Dahl salt-sensitive hypertension and renal disease. Am J Physiol Renal Physiol (2008) 1.37

Genomic map of cardiovascular phenotypes of hypertension in female Dahl S rats. Physiol Genomics (2003) 1.37

Epoxygenase-driven angiogenesis in human lung microvascular endothelial cells. Am J Physiol Heart Circ Physiol (2002) 1.34

Beneficial effects of a new 20-hydroxyeicosatetraenoic acid synthesis inhibitor, TS-011 [N-(3-chloro-4-morpholin-4-yl) phenyl-N'-hydroxyimido formamide], on hemorrhagic and ischemic stroke. J Pharmacol Exp Ther (2005) 1.31

Antinociception produced by 14,15-epoxyeicosatrienoic acid is mediated by the activation of beta-endorphin and met-enkephalin in the rat ventrolateral periaqueductal gray. J Pharmacol Exp Ther (2008) 1.30

Increased blood pressure in mice lacking cytochrome P450 2J5. FASEB J (2008) 1.30

Elevations in renal interstitial hydrostatic pressure and 20-hydroxyeicosatetraenoic acid contribute to pressure natriuresis. Hypertension (2007) 1.29

Effect of sodium delivery on superoxide and nitric oxide in the medullary thick ascending limb. Am J Physiol Renal Physiol (2006) 1.26

Cerebral capillary endothelial cell mitogenesis and morphogenesis induced by astrocytic epoxyeicosatrienoic Acid. Stroke (2002) 1.25

Chromosomal mapping of the genetic basis of hypertension and renal disease in FHH rats. Am J Physiol Renal Physiol (2007) 1.24

Increased renal medullary oxidative stress produces hypertension. Hypertension (2002) 1.24

20-HETE-mediated cytotoxicity and apoptosis in ischemic kidney epithelial cells. Am J Physiol Renal Physiol (2008) 1.22

Role of 20-hydroxyeicosatetraenoic acid and epoxyeicosatrienoic acids in hypertension. Curr Opin Nephrol Hypertens (2004) 1.21

Transforming growth factor-beta, 20-HETE interaction, and glomerular injury in Dahl salt-sensitive rats. Hypertension (2005) 1.20

Neuroprotection and P450 2C11 upregulation after experimental transient ischemic attack. Stroke (2002) 1.19

9L gliosarcoma cell proliferation and tumor growth in rats are suppressed by N-hydroxy-N'-(4-butyl-2-methylphenol) formamidine (HET0016), a selective inhibitor of CYP4A. J Pharmacol Exp Ther (2005) 1.19

Human U251 glioma cell proliferation is suppressed by HET0016 [N-hydroxy-N'-(4-butyl-2-methylphenyl)formamidine], a selective inhibitor of CYP4A. J Pharmacol Exp Ther (2005) 1.19

Effect of 20-HETE inhibition on infarct volume and cerebral blood flow after transient middle cerebral artery occlusion. J Cereb Blood Flow Metab (2008) 1.19

Effect of a new inhibitor of the synthesis of 20-HETE on cerebral ischemia reperfusion injury. Stroke (2006) 1.18

Metabotropic glutamate receptor activation enhances the activities of two types of Ca2+-activated k+ channels in rat hippocampal astrocytes. J Neurosci (2003) 1.15

Influence of diet and genetics on hypertension and renal disease in Dahl salt-sensitive rats. Physiol Genomics (2004) 1.15

Dependency of cortical functional hyperemia to forepaw stimulation on epoxygenase and nitric oxide synthase activities in rats. J Cereb Blood Flow Metab (2004) 1.15

Effects of a 20-HETE antagonist and agonists on cerebral vascular tone. Eur J Pharmacol (2004) 1.14

Overview on the application of transcription profiling using selected nephrotoxicants for toxicology assessment. Environ Health Perspect (2004) 1.14

Protective effect of 20-HETE analogues in experimental renal ischemia reperfusion injury. Kidney Int (2008) 1.13

Antihypertensive effects of chronic anti-TGF-beta antibody therapy in Dahl S rats. Am J Physiol Regul Integr Comp Physiol (2002) 1.12

CYP4A metabolites of arachidonic acid and VEGF are mediators of skeletal muscle angiogenesis. Am J Physiol Heart Circ Physiol (2003) 1.12

Effects of a new SGLT2 inhibitor, luseogliflozin, on diabetic nephropathy in T2DN rats. J Pharmacol Exp Ther (2013) 1.12

Effects of cytochrome P-450 metabolites of arachidonic acid on the epithelial sodium channel (ENaC). Am J Physiol Renal Physiol (2011) 1.11

Role of superoxide and angiotensin II suppression in salt-induced changes in endothelial Ca2+ signaling and NO production in rat aorta. Am J Physiol Heart Circ Physiol (2006) 1.10

Role of astrocytes in matching blood flow to neuronal activity. Curr Top Dev Biol (2007) 1.10

RF-2 gene modulates proteinuria and albuminuria independently of changes in glomerular permeability in the fawn-hooded hypertensive rat. J Am Soc Nephrol (2005) 1.09

BN phenome: detailed characterization of the cardiovascular, renal, and pulmonary systems of the sequenced rat. Physiol Genomics (2006) 1.09

20-HETE contributes to the acute fall in cerebral blood flow after subarachnoid hemorrhage in the rat. Am J Physiol Heart Circ Physiol (2002) 1.08

20-HETE mediates proliferation of renal epithelial cells in polycystic kidney disease. J Am Soc Nephrol (2008) 1.08

Effects of 20-HETE on Na+ transport and Na+ -K+ -ATPase activity in the thick ascending loop of Henle. Am J Physiol Regul Integr Comp Physiol (2007) 1.08

Dynamic convergence and divergence of renal genomic and biological pathways in protection from Dahl salt-sensitive hypertension. Physiol Genomics (2009) 1.06

Transfer of the CYP4A region of chromosome 5 from Lewis to Dahl S rats attenuates renal injury. Am J Physiol Renal Physiol (2008) 1.06

Renal effects of glucagon-like peptide in rats. Eur J Pharmacol (2002) 1.06

Fenofibrate prevents the development of angiotensin II-dependent hypertension in mice. Hypertension (2005) 1.05

Interaction of nitric oxide, 20-HETE, and EETs during functional hyperemia in whisker barrel cortex. Am J Physiol Heart Circ Physiol (2008) 1.05

20-HETE activates the Raf/MEK/ERK pathway in renal epithelial cells through an EGFR- and c-Src-dependent mechanism. Am J Physiol Renal Physiol (2009) 1.05

Expression of CYP4A1 in U251 human glioma cell induces hyperproliferative phenotype in vitro and rapidly growing tumors in vivo. J Pharmacol Exp Ther (2008) 1.03

Emerging mechanisms for growth and protection of the vasculature by cytochrome P450-derived products of arachidonic acid and other eicosanoids. Prostaglandins Other Lipid Mediat (2006) 1.02

Genetic basis of the impaired renal myogenic response in FHH rats. Am J Physiol Renal Physiol (2012) 1.02

Contributions of 20-HETE to the antihypertensive effects of Tempol in Dahl salt-sensitive rats. Hypertension (2002) 1.02

Role of 20-HETE in the hypoxia-induced activation of Ca2+-activated K+ channel currents in rat cerebral arterial muscle cells. Am J Physiol Heart Circ Physiol (2007) 1.02

NO synthase uncoupling in the kidney of Dahl S rats: role of dihydrobiopterin. Hypertension (2006) 1.01

Contribution of 5-hydroxytryptamine1B receptors and 20-hydroxyeiscosatetraenoic acid to fall in cerebral blood flow after subarachnoid hemorrhage. Stroke (2003) 1.00

Role of 20-HETE in the pial arteriolar constrictor response to decreased hematocrit after exchange transfusion of cell-free polymeric hemoglobin. J Appl Physiol (1985) (2005) 1.00

Mechanisms regulating cerebral blood flow as therapeutic targets. Curr Opin Investig Drugs (2004) 1.00

Hydrogen peroxide induces nitric oxide and proteosome activity in endothelial cells: a bell-shaped signaling response. Free Radic Biol Med (2007) 1.00

Renal medullary nitric oxide deficit of Dahl S rats enhances hypertensive actions of angiotensin II. Am J Physiol Regul Integr Comp Physiol (2002) 1.00

Evaluation of metalloprotease inhibitors on hypertension and diabetic nephropathy. Am J Physiol Renal Physiol (2011) 0.99

Postmenopausal hypertension: role of 20-HETE. Am J Physiol Regul Integr Comp Physiol (2011) 0.98

Down-regulation of 20-HETE synthesis and signaling inhibits renal adenocarcinoma cell proliferation and tumor growth. Anticancer Res (2009) 0.98

Identification of a QTL on chromosome 1 for impaired autoregulation of RBF in fawn-hooded hypertensive rats. Am J Physiol Renal Physiol (2005) 0.98

Inhibitors of 20-HETE formation promote salt-sensitive hypertension in rats. Hypertension (2003) 0.98

Role of endogenous CYP450 metabolites of arachidonic acid in maintaining the glomerular protein permeability barrier. Am J Physiol Renal Physiol (2007) 0.97

A 20-hydroxyeicosatetraenoic acid agonist, N-[20-hydroxyeicosa-5(Z),14(Z)-dienoyl]glycine, opposes the fall in blood pressure and vascular reactivity in endotoxin-treated rats. Shock (2008) 0.97

Distribution of cytochrome P-450 4A and 4F isoforms along the nephron in mice. Am J Physiol Renal Physiol (2002) 0.97

Initial characterization of a rat model of diabetic nephropathy. Diabetes (2004) 0.97

Substitution of chromosome 1 ameliorates L-NAME hypertension and renal disease in the fawn-hooded hypertensive rat. Am J Physiol Renal Physiol (2005) 0.97

Role of medullary blood flow in the pathogenesis of renal ischemia-reperfusion injury. Curr Opin Nephrol Hypertens (2012) 0.97

Integration of hypoxic dilation signaling pathways for skeletal muscle resistance arteries. Am J Physiol Regul Integr Comp Physiol (2002) 0.97

Elevated BSC-1 and ROMK expression in Dahl salt-sensitive rat kidneys. Hypertension (2004) 0.97

Postmenopausal hypertension: role of the sympathetic nervous system in an animal model. Am J Physiol Regul Integr Comp Physiol (2013) 0.96

Identification of a novel cytochrome P450, CYP4X1, with unique localization specific to the brain. Biochem Biophys Res Commun (2002) 0.96

Role of 20-HETE in the antihypertensive effect of transfer of chromosome 5 from Brown Norway to Dahl salt-sensitive rats. Am J Physiol Regul Integr Comp Physiol (2012) 0.96

Recommendations of the National Heart, Lung, and Blood Institute working group on cerebrovascular biology and disease. Stroke (2006) 0.96

Nitric oxide contributes to 20-HETE-induced relaxation of pulmonary arteries. J Appl Physiol (1985) (2002) 0.95

Narrowing a region on rat chromosome 13 that protects against hypertension in Dahl SS-13BN congenic strains. Am J Physiol Heart Circ Physiol (2011) 0.95

Antiangiogenic effect of inhibitors of cytochrome P450 on rats with glioblastoma multiforme. J Cereb Blood Flow Metab (2008) 0.95